[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342610-105":59,"doc-detail-342610-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","antibody-profiling-of-pan-cancer-viral-proteome-reveals-biomarkers-for-nasopharyngeal-carcinoma-diagnosis-and-prognosis","Antibody Profiling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis","","Measures IgA and IgG antibody responses against 646 viral proteins from 23 viruses in nasopharyngeal carcinoma (NPC) patients and controls using nucleic acid programmable protein arrays. Identifies five anti–Epstein-Barr virus (EBV) antibodies combining with EBV nuclear antigen 1 (EBNA1) IgA for accurate NPC diagnosis, and two anti-EBV antibodies as potential prognostic biomarkers. Validates candidates by ELISA across 1665 sera from three clinical cohorts and highlights a six-antibody signature with diagnostic performance comparable to current markers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/antibody-profiling-of-pan-cancer-viral-proteome-reveals-biomarkers-for-nasopharyngeal-carcinoma-diagnosis-and-prognosis/342610/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/antibody-profiling-of-pan-cancer-viral-proteome-reveals-biomarkers-for-nasopharyngeal-carcinoma-diagnosis-and-prognosis/342610.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":56},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What assay was used to profile antibody responses in the study?","Question",{"text":112,"@type":113},"The study used nucleic acid programmable protein arrays to measure IgA and IgG responses against 646 viral proteins from 23 viruses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biomarkers were proposed for diagnosing nasopharyngeal carcinoma?",{"text":117,"@type":113},"Five anti-EBV antibodies were combined with the clinical biomarker EBNA1 IgA to diagnose NPC accurately, forming a six-antibody signature.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the study assess prognosis in relation to antibody levels?",{"text":121,"@type":113},"It evaluated whether titers of specific seromarkers correlated with disease-free survival, showing poorer survival for NPC patients with elevated BLLF3-IgA and BDLF1-IgA.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342610,1790179436,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":56,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Antibody Proﬁling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis  \nAuthors  \nTe Liang, Hao Chen, Lei Liu, Yongqiang Zheng, Zhaoen Ma, Ling Min, Jiahui Zhang, Lianfu Wu, Jie Ma, Zexian Liu, Qingfeng Zhang, Kai Luo, Di Hu, Tianxing Ji, and Xiaobo Yu  \nCorrespondence [jitianxing7021@163.com](jitianxing7021@163.com) ; [yuxiaobo@mail.ncpsb.org](yuxiaobo@mail.ncpsb.org)  \nIn Brief  \nThis study measured IgA and IgG antibody responses against 646 viral proteins from 23 viruses innasopharyngeal carcinoma (NPC) patients and controls using nucleic acid programmable protein arrays. We found that ﬁve anti-Epstein-Barr virus (EBV) antibodies combined with the clinical biomarker EBV nuclear antigen 1 (EBNA1) IgA could be used to diagnose NPC accurately. Additionally, two anti-EBV antibodies showed potential as prognostic biomarkers of NPC. These results indicate the possibility of developing new serological tests for NPC detection and prognosis.  \nGraphical Abstract  \nHighlights  \n• Determined the serum antibody proﬁles of NPC patients using viral proteome arrays.  \n• Examined the association between antiviral antibodies to multiple viruses and NPC.  \n• Provided new potential seromarkers for the diagnosis and prognosis of NPC.  \n2024, Mol Cell Proteomics 23(3), 100729  \n© 2024 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY license ([http://creativecommons.org/](http://creativecommons.org/)[ ](http://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)).  \n[https://doi.org/10.1016/j.mcpro.2024.100729](https://doi.org/10.1016/j.mcpro.2024.100729)  \n RESEARCH  \nAntibody Proﬁling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis  \nTe Liang 1 ,‡, Hao Chen2 ,‡, Lei Liu3 ,‡, Yongqiang Zheng2 ,‡ , Zhaoen Ma4 ,‡, Ling Min5 ,‡, Jiahui Zhang3, Lianfu Wu3 , Jie Ma3, Zexian Liu2, Qingfeng Zhang2, Kai Luo5, Di Hu6,  \nTianxing Ji7 ,* , and Xiaobo Yu3 ,*  \nDiagnosing, predicting disease outcome, and identifying effective treatment targets for virus-related cancers are lacking. Protein biomarkers have the potential to bridge the gap between prevention and treatment for these types of cancers. While it has been shown that certain antibodies against EBV proteins could be used to detect nasopharyngeal carcinoma (NPC), antibodies targeting are solely a tiny part of the about 80 proteins expressed by the EBV genome. Furthermore, it remains unclear what role other viruses play in NPC since many diseases are the result of multiple viral infections. For the ﬁrst time, this study measured both IgA and IgG antibody responses against 646 viral proteins from 23 viruses in patients with NPC and control subjects using nucleic acid programmable protein arrays. Candidate seromarkers were then validated by ELISA using 1665 serum samples from three clinical cohorts. We demonstrated that the levels of ﬁve candidate seromarkers (EBV-BLLF3-IgA, EBV-BLRF2-IgA, EBV-BLRF2-IgG, EBV-BDLF1-IgA, EBV-BDLF1-IgG) in NPC patients were signiﬁcantly elevated than controls. Additional examination revealed that NPC could be successfully diagnosed by combining the clinical biomarker EBNA1-IgA with the ﬁve anti-EBV antibodies. The sensitivity of the six-antibody signature at 95% speciﬁcity to diagnose NPC was comparable to the current clinicallyapproved biomarker combination, VCA-IgA, and EBNA1-IgA. However, the recombinant antigens of the ﬁve antibodies are easier to produce and standardize compared to the native viral VCA proteins. This suggests the potential replacement of the traditional VCA-IgA assay with the 5-antibodies combination to screen and diagnose NPC. Additionally, we investigated the prognostic signiﬁcance  \nof these seromarkers titers in NPC. We showed that NPC patients with elevated BLLF3-IgA and BDLF1-IgA titers in their serum exhibited signiﬁcantly poorer disea","cbCaig4R6sfYsVEE","https://ap.wps.com/l/cbCaig4R6sfYsVEE","pdf",4496969,11,"English","# In Brief\n# Highlights\n# Research\n## Antibody profiling and diagnostic signature\n## Prognostic evaluation\n# Background and clinical significance","[{\"question\":\"What assay was used to profile antibody responses in the study?\",\"answer\":\"The study used nucleic acid programmable protein arrays to measure IgA and IgG responses against 646 viral proteins from 23 viruses.\"},{\"question\":\"Which biomarkers were proposed for diagnosing nasopharyngeal carcinoma?\",\"answer\":\"Five anti-EBV antibodies were combined with the clinical biomarker EBNA1 IgA to diagnose NPC accurately, forming a six-antibody signature.\"},{\"question\":\"How did the study assess prognosis in relation to antibody levels?\",\"answer\":\"It evaluated whether titers of specific seromarkers correlated with disease-free survival, showing poorer survival for NPC patients with elevated BLLF3-IgA and BDLF1-IgA.\"}]","Antibody Profiling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis | PDF",1790047382,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77d70c1e1b2191c541e43f7b70a1c400.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5796fa1dd847115396f27947405ddeb6.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33092c64a06a7f30a7f2ca16dc864055.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/645369cd2eef9bed9bf4515811f2a352.webp",980,1292]